SCHEMBL5542224

SCHEMBL5542224

CCNc1ccc(C=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
ALDH1A1 P00352 6/20 0.48
ALDH1A3 P47895 3/20 0.48
ALDH3A1 P30838 2/20 0.48
LMNA P02545 2/20 0.47
CYP2A6 P11509 4/20 0.46
ADRA2A P08913 3/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
TYR P14679 1/20 0.41
CYP2A13 Q16696 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH5A1 P51649 1/20 0.41
ABAT P80404 1/20 0.41
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5172276 0.84 MAPT (0.45) MAPTALDH1A1LMNAADRA2AADRA2B
SCHEMBL5534383 0.83 ALDH1A1 (0.45) MAPTALDH1A1ALDH1A3ALDH3A1LMNA
SCHEMBL12387901 0.81 MAPT (0.47) MAPTLMNAADRA2AADRA2BADRA2C
SCHEMBL14423965 0.81 CYP2A6 (0.44) ALDH1A1ALDH1A3ALDH3A1CYP2A6TYR
SCHEMBL8533249 0.81 MAPT (0.47) MAPTLMNAADRA2AADRA2BADRA2C
SCHEMBL526383 0.80 MAPT (0.58) MAPTALDH1A1LMNAADRA2AADRA2B
SCHEMBL9391329 0.79 ALDH1A1 (0.48) MAPTALDH1A1LMNAADRA2AADRA2B
Dimethylamine SCHEMBL5736373 0.79 ALDH1A1 (0.42) MAPTALDH1A1ALDH1A3ALDH3A1LMNA
SCHEMBL5493605 0.79 LMNA (0.43) MAPTALDH1A1ALDH1A3ALDH3A1LMNA
SCHEMBL13024625 0.78 MAPT (0.42) MAPTALDH1A1LMNAADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
JP-56029586-A None JP disclosed
CN-118930497-A Conjugate of c-di-GMP G-quadruplex inducer and NO donor and application thereof in antibacterial biomembrane 暨南大学 2024-11-12 CN disclosed
CN-118894809-A Isoliminox derivative and preparation method and application thereof 深圳市新产业生物医学工程股份有限公司 2024-11-05 CN disclosed
US-20230050846-A1 TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERS UNIVERSITÉ PAUL SABATIER TOULOUSE III (FR) 2023-02-16 US disclosed
WO-2021123300-A1 TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERS LIFESEARCH (FR) 2021-06-24 WO disclosed
EP-2917203-B1 METHOD FOR IDENTIFYING MYC INHIBITORS DANA FARBER CANCER INST INC (US) 2019-04-03 EP disclosed
CN-103571456-A Fluorescence probe for detecting nitrosyl peroxide by utilizing amido bond rupture and application of fluorescence probe DALIAN CHEMICAL PHYSICS INST 2014-02-12 CN disclosed
WO-2013148892-A1 BENZYLIDENE DERIVATIVE CHROMOPHORES FOR PHOTOREFRACTIVE COMPOSITIONS NITTO DENKO CORPORATION (JP) 2013-10-03 WO disclosed
US-20130170016-A1 PHOTOREFRACTIVE DEVICE CONTAINING A CHROMOPHORE-DOPED POLYMER LAYER AND ITS MANUFACTURING METHOD NITTO DENKO CORPORATION (JP) 2013-07-04 US disclosed
US-5443758-A A ketone cis- or trans-gonanes; nonlinear optical response HATACHI CHEMICAL COMPANY, LTD. (JP) 1995-08-22 US disclosed
EP-0290610-B1 METHOD FOR INSPECTING BODILY FLUIDS DAINIPPON PRINTING CO LTD (JP) 1994-08-17 EP disclosed
EP-0605394-A1 Device for testing body fluids DAI NIPPON INSATSU KABUSHIKI KAISHA (JP) 1994-07-06 EP disclosed
US-5262090-A Electrooptical switches HITACHI CHEMICAL COMPANY, LTD. (JP) 1993-11-16 US disclosed
US-5208341-A Pressure sensitive copying; thermoreactive or electrochromic recording materials BAYER AKTIENGESELLSCHAFT (DE) 1993-05-04 US disclosed
US-5178831-A Colorimetric analysis for medical diagnosis DAI NIPPON INSATSU KAB USHIKI KAISHA 1993-01-12 US disclosed
EP-0480276-A2 Carbonylaminostyrene derivatives as recording material BAYER AG (DE) 1992-04-15 EP disclosed
EP-0465155-A2 Non-linear optical material containing steroidal ketone compound Hitachi Chemical Co., Ltd. (JP) 1992-01-08 EP disclosed
EP-0290610-A1 METHOD FOR INSPECTING BODILY FLUIDS DAI NIPPON INSATSU KABUSHIKI KAISHA (JP) 1988-11-17 EP disclosed
JP-S5629586-A 2,6-DI-TERT-BUTYL-4- 4- DIETHYLAMINO STYRYL THIOPYRYLIUM SALT AND ITS PREPARATION FUJI PHOTO FILM CO LTD 1981-03-24 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230050846-A1 TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERS FABP1, FABP3, PCSK9 MAPT 3463/4885ALDH1A1 974/4885ALDH1A3 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.